Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond

NCT06678919 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.

NCT NCT06678919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06678919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond
Lead sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2024
Completion date
December 31, 2034
Enrollment
500 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer (mcrc)